ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
24 announcements
Infomerics upgraded Ambani Orgochem's bank loan ratings to IVR BBB-/Stable and removed them from Issuer Not Cooperating. The action reflects improved financial risk profile.
H1 FY27 consolidated revenue +54.87% to ₹171.22 Cr; PAT ₹3.45 Cr from ₹0.19 Cr. EBITDA +43% but margin slipped; management gives no numeric guidance.
Ambani Orgochem announced the resignation of non-executive non-independent director Bhavin Patel, effective 29 October 2026. The resignation was attributed to professional priorities and commitments.
Ambani Orgochem members approved a Rs 43.93 Crore preferential warrant issue and capital changes. Promoters receive 30.1 lakh of the 43.93 lakh warrants.
H1 FY27 consolidated: revenue ₹171.22 cr (+54.87%), EBITDA ₹11.32 cr (+43.00%), PAT ₹3.45 cr vs ₹0.19 cr. Strategy: capacity expansion and downstream specialty chemicals.
Ambani Orgochem's 1st EGM on 26 October 2026 took up four special resolutions. Items cover authorised capital, the capital clause, and preferential warrants.
Ambani Orgochem issued a corrigendum to its EGM notice, reducing the proposed preferential issue size of convertible warrants to Rs. 43.925 Crore following allotment revisions.
Ambani Orgochem reduced its proposed preferential issue of convertible warrants by Rs. 0.25 Crore, following the removal of one allottee. The revised issue size is Rs. 43.925 Crore.
The company submitted its Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026, in compliance with SEBI Regulation 76.
Ambani Orgochem Limited seeks shareholder approval at an EGM to issue 43.95 lakh convertible warrants at Rs. 100 each, raising Rs. 43.95 Crore.
Ambani Orgochem Limited announced the appointment of two Independent Directors, Rajesh Desai and Mahesh Jagdale, for five-year terms. Additionally, Bhavin Patel was re-appointed as a Non-Executive Director.
Ambani Orgochem approved a preferential issue of 43,95,000 warrants to ten allottees. This fund-raising proposal is subject to shareholder approval at the upcoming EGM.
Ambani Orgochem Limited held its 40th Annual General Meeting on September 26, 2026, to adopt financial statements and approve various director-related resolutions.
Ambani Orgochem Limited presents its specialty chemical platform, focusing on capacity expansion in Peroxides, Salicylates, and Acrylic Coatings.
Ambani Orgochem Limited submitted its Annual Report for FY 2025-26 and the Notice for the 40th Annual General Meeting scheduled for September 26, 2026.
Ambani Orgochem Limited announced its 40th Annual General Meeting for September 2026. The board approved the AGM notice and fixed book closure dates.
Ambani Orgochem Limited filed a revised Structured Digital Database (SDD) compliance certificate for the financial year ended March 31, 2026, as required under SEBI regulations.
Ambani Orgochem Limited appointed Mr. Mahesh Shrirang Jagdale as an Additional Non-Executive Independent Director, effective July 24, 2026.
Ambani Orgochem reported record Q1 FY27 revenue with 49% YoY growth. The update, based on unaudited data, highlights resilience post-fire incident and strong operational execution.
Board approved 12% dividend on preference shares and redemption of 28.45 lakh shares worth Rs.2.85 Crore. This reduces preference capital and returns funds to shareholders.
Ambani Orgochem allotted 9,79,810 equity shares upon conversion of warrants at Rs.90 each, raising Rs.8.82 Crore. This strengthens the company's equity base and reduces outstanding warrants.
Ambani Orgochem Ltd reported revenue from operations of ₹131.6 Cr (+18.8% YoY) and net profit of ₹1.1 Cr (+22.2% YoY) for H2 FY26.
Ambani Orgochem Limited reported its audited financial results for the year ended March 31, 2026. The board approved results showing significantly improved year-on-year revenue performance.
Ambani Organics Limited informed the NSE that Corporate Governance Provisions under Regulation 27(2) are not applicable as its shares are listed on the SME Platform. Consequently, the company is not required to submit a Corporate Governance Report for the quarter ended March 31, 2026.